Capital Drug 360 offers a turnkey solution to help pharmacies confidently meet DSCSA dispenser requirements. From onboarding and EPCIS data exchange to electronic verification and audit-ready documentation, Capital Drug 360 provides a streamlined path to compliance, with no setup fee and two months of complimentary access for qualifying customers.

Key Features:

• Authorized Trading Partner Management: Ensures pharmacies only receive product from verified ATPs through seamless exchange setup and ongoing validation.
  
  
• End-to-End Traceability Documentation: Automates capture and secure transmission of transaction details and EPCIS data, with digital SOPs maintained per FDA guidelines.
  
  
• Product Verification & Quarantine Support: Enables scanning of package-level data, supports quarantine of suspect products, and facilitates FDA notification and tracing within 48 hours.
  
  
• Subscription-Based Access: Designed with pharmacy budgets in mind—no implementation charges, and generic purchasing pharmacies receive two free months of access.
  
  
• Compliance Guidance & Resources: Offers SOP development, staff training, and ongoing support to help ensure readiness for audits and inspections.
  
  

Capital Drug 360 empowers pharmacies to meet DSCSA requirements while maintaining operational efficiency and focusing on patient care.